Establishment Labs appoints Paul D. Rodio as COO, effective Dec 1, 2022

ESTABLISHMENT LABS HOLDINGS INC.

Appointed Paul D. Rodio as COO effective Dec 1, 2022; prior roles at Cardinal Health, Medtronic, and Covidien.
Base salary of $375,000 annually; target annual bonus up to 50% of base salary.
New hire stock option grant to purchase 50,000 common shares, vesting over 4 years (1/4 per year).
Eligible for annual equity awards beginning 2024 with grant date fair value ~150% of base salary.
Severance: 9 months base salary (non-CIC) or 12 months base salary (CIC), plus bonus and health benefits.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Paul D. Rodio

Chief Operating Officer

ESTA · ESTABLISHMENT LABS HOLDINGS INC.

Effective: 2022-12-01
Filed: December 2, 2022, 6:59 PM ET

The Board of Directors of Establishment Labs Holdings Inc. (the “Company”) has appointed Paul D. Rodio to the position of Chief Operating Officer of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Paul D. Rodio was appointed as Chief Operating Officer at ESTABLISHMENT LABS HOLDINGS INC..

Action: appointed
Role: Chief Operating Officer

Exact text from the filing

The Board of Directors of Establishment Labs Holdings Inc. (the “Company”) has appointed Paul D. Rodio to the position of Chief Operating Officer of the Company.

View on SEC.gov

ESTABLISHMENT LABS HOLDINGS INC. filing history →

Source: SEC EDGAR

accession 0001688757-22-000108

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.